BackAngiodynamic Overview
Angiodynamic Inc

Angiodynamic Target Price

Analysts' average 12-month price target for Angiodynamic is $20.

Get informed when a big investor buys or sells

+ Follow

Share Price

$15.42

Average Target Price

$19.5026.5% upside

2 analysts in the last 4 months

High: $20 | Low: $19

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-07-15H.C. WainwrightYi Chen$1923.2% upsideOpen
2026-07-15Canaccord Genuity$2029.7% upsideOpen
2025-10-03Canaccord Genuity$1816.7% upsideOpen
2025-07-16Canaccord GenuityJohn Young$1710.2% upsideOpen
2024-10-04Canaccord GenuityWilliam Plovanic$1222.2% downsideOpen
2024-09-20H.C. WainwrightYi Chen$149.2% downsideOpen
2024-04-05OppenheimerSteven Lichtman$1222.2% downsideOpen
2023-01-06Raymond James$2242.7% upsideOpen
2022-07-13Raymond James$2775.1% upsideOpen

Angiodynamic (ANGO) FAQ

Angiodynamic posts a target price of $20. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

A target price of $20 for ANGO means covering analysts, on average, see the stock 26.5% upside of $15.42 over about 12 months. Dig into who set the high and low targets and how recently they updated — freshness matters as much as the average itself.

Context for ANGO's target price usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Angiodynamic's other metric pages and overview cover the third.

Judging Angiodynamic against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in target price easier to interpret. Start with $20 here, then scan peer and history charts to see if the gap is persistent.